R. Selik, R. Byers, J. Dworkin, and M. , Trends in Diseases Reported on U.S. Death Certificates That Mentioned HIV Infection, 1987???1999, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.29, issue.4, p.378, 2002.
DOI : 10.1097/00126334-200204010-00009

H. Krentz, G. Kliewer, and M. Gill, Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003, HIV Medicine, vol.15, issue.2, p.99, 1984.
DOI : 10.1097/00001432-200310000-00015

F. Palella, J. Baker, R. Moorman, and A. , Mortality in the Highly Active Antiretroviral Therapy Era, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.1, p.27, 2006.
DOI : 10.1097/01.qai.0000233310.90484.16

J. Currier, J. Lundgren, and A. Carr, Epidemiological Evidence for Cardiovascular Disease in HIV-Infected Patients and Relationship to Highly Active Antiretroviral Therapy, Circulation, vol.118, issue.2, p.29, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.189624

J. Sackoff, D. Hanna, M. Pfeiffer, and L. Torian, Causes of Death among Persons with AIDS in the Era of Highly Active Antiretroviral Therapy: New York City, Annals of Internal Medicine, vol.145, issue.6, p.397, 2006.
DOI : 10.7326/0003-4819-145-6-200609190-00003

N. Crum, R. Riffenburgh, and S. Wegner, Comparisons of Causes of Death and Mortality Rates Among HIV-Infected Persons, Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in, pp.492-504, 2001.
DOI : 10.1097/01.qai.0000179459.31562.16

C. Grunfeld, J. Delaney, and C. Wanke, Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study Serious fatal and nonfatal non-AIDSdefining illnesses in Europe, AIDS J Acquir Immune Defic Syndr, vol.23, issue.552, p.262, 2009.

C. Roussillon, S. Hénard, J. Greenwald, and A. Richterman, Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection Racial disparities in hypertension prevalence, awareness, and management General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era, AIDS; Arch Intern Med Kilbourne AM J Clin Epidemiol, vol.24, issue.54, pp.1509-1526, 2001.

J. Goulet, S. Fultz, and D. Rimland, Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Prevalence and patient awareness of medical comorbidities in an urban AIDS clinic Factors associated with non-adherence to antiretroviral therapy in the SUN study dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression, ): 601. 22. Gross R, Yip B, pp.1593-1108, 2006.

M. Martin, D. Cacho, E. Codina, and C. , Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions, AIDS Res Hum Retroviruses HIV Med, vol.24, issue.147, p.430, 2008.

B. Jonnson, P. Cook, M. Mccabe, S. Emiliozzi, L. Pointer et al., Telephone nurse counseling improves HIV medication adherence: an effectiveness study Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study Nurse-delivered antiretroviral treatment adherence intervention for people with low literacy skills and living with HIV/AIDS Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial Strategies for coping in a complex world: adherence behavior among older adults with chronic illness, Sweden. International Journal of Technology Assessment in Health Care, pp.234-260, 1992.

J. Piette and E. Kerr, The Impact of Comorbid Chronic Conditions on Diabetes Care, Diabetes Care, vol.29, issue.3, p.725, 2006.
DOI : 10.2337/diacare.29.03.06.dc05-2078

D. Redelmeier, S. Tan, G. Booth, B. Turner, C. Hollenbeak et al., The Treatment of Unrelated Disorders in Patients with Chronic Medical Diseases, Tourette-Turgis C, Rébillon M. Mettre en place une consultation d'observance aux traitements contre le VIH/SIDA -De la théorie à la pratique, pp.1516-1549, 1998.
DOI : 10.1056/NEJM199805213382106

C. Mchorney, The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease, Current Medical Research and Opinion, vol.25, issue.1, p.215, 2009.
DOI : 10.1185/03007990802619425

G. Wagner, D. Kanouse, P. Koegel, and G. Sullivan, Adherence to HIV Antiretrovirals among Persons with Serious Mental Illness, AIDS Patient Care and STDs, vol.17, issue.4, pp.179-86, 2003.
DOI : 10.1089/108729103321619782

C. Fumaz, J. Munoz-moreno, and A. Ballesteros, Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients, AIDS Care, vol.4, issue.1, p.11, 1996.
DOI : 10.1097/00005650-199206000-00002

R. Hagger, . Ms, and . Os, A Meta-Analytic Review of the Common-Sense Model of Illness Representations, Psychology & Health, vol.67, issue.2, p.141, 2003.
DOI : 10.1111/j.1600-0447.1983.tb09716.x

T. H. Leventhal, . Dm, E. Leventhal, A. Kurian, K. Cardarelli et al., Illness cognition: using commonsense to understand treatment adherence and affect cognition interactions Racial and ethnic differences in cardiovascular disease risk factors: a systematic review Disparities in adherence to hypertensive care in urban ambulatory settings Understanding contributors to racial disparities in blood pressure control, ): 132. 43. Kressin NR, pp.143-184, 1992.

R. Horne, L. Graupner, S. Frost, J. Weinman, S. Wright et al., HIV illness representation as a predictor of self-care management and health outcomes: a multi-site, cross-cultural study Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV Overcoming racial and ethnic disparities in blood pressure control: a patient-centered approach to cross-cultural communication Perspectives of non-Hispanic Black and Latino patients in Boston's urban community health centers on their experiences with diabetes and hypertension, al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America, pp.1307-1352, 2004.

M. Humphreys, G. Lucas, J. Eustace, S. Sozio, E. Mentari et al., Human immunodeficiency virus-associated glomerulosclerosis Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study HIV-associated nephropathy Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy, A8. 54. Dauchy FA, pp.311-51, 1995.

V. Jotwani, Y. Li, C. Grunfeld, A. Choi, M. Shlipak et al., Risk factors for ESRD in HIVinfected individuals: traditional and HIV-related factors Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators Electronic monitoring of compliance to lipidlowering therapy in clinical practice Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients, Measurement of anticonvulsant adherence behaviour in the community using a Medication Events Monitoring System (MEMS), pp.628-56, 1998.

K. Melbourne, S. Geletko, S. Brown, C. Willey-lessne, S. Chase et al., Medication adherence in patients with HIV infection: a comparison of two measurement methods): 329. 61. van den Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, 632. 62. Charlson ME, p.373, 1987.

J. Weinman, . Pk, R. Moss-morris, R. Horne, A. Beck et al., The Illness Perception Questionnaire : A new method for assessing the cognitive representation of illness Comparison of Beck Depression Inventories - IA and -II in psychiatric outpatients The Substance Use Disorders Module of the Structured Clinical DSM-IV, 66. Smith A. Symbol Digit Modalities Test (SDMT): Manuel (Revised). Los Angeles: Western Psychological Services, p.431, 1982.

R. Reitan, L. Thompson, and R. Heaton, Validity of the Trail Making Test as an indication of organic brain damage, Percept Motor Skill, vol.8, 1958.

F. Lutz, D. Baker, M. Williams, R. Parker, J. Gazmararian et al., Development of a brief test to measure functional health literacy Compliance in hypertension: facts and concepts Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study, Patient Educ Couns J Hypertens Suppl AIDS, vol.38, issue.2410, p.1537, 1985.

H. Liu, C. Golin, and L. Miller, Adherence to protease inhibitor therapy and outcomes in patients with HIV infection): 21. 74 Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations Electronic monitoring of patient adherence to oral antihypertensive medical treatment: a systematic review Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories): 1114. 77. Schoenthaler A, Ogedegbe G. Patients' perceptions of electronic monitoring devices affect medication adherence in hypertensive African Americans Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial Use of electronic monitoring induces a 40-day intervention effect in HIV patients, Ann Intern Med Ann Intern Med AIDS Behav J Hypertens BMJ Ann Pharmacother Am J Hypertens Deschamps AE J Acquir Immune Defic Syndr, vol.134, issue.432, pp.968-73, 2000.

E. Gardner, W. Burman, M. Maravi, and A. Davidson, Durability of Adherence to Antiretroviral Therapy on Initial and Subsequent Regimens, AIDS Patient Care and STDs, vol.20, issue.9, p.628, 2006.
DOI : 10.1089/apc.2006.20.628

J. Parienti, D. Bangsberg, R. Verdon, and E. Gardner, Better Adherence with Once???Daily Antiretroviral Regimens: A Meta???Analysis, Clinical Infectious Diseases, vol.48, issue.4, p.484, 2009.
DOI : 10.1086/596482

L. Couzi, B. Moulin, and M. Morin, Factors Predictive of Medication Nonadherence After Renal Transplantation, Transplantation Journal, vol.95, issue.2, p.326
DOI : 10.1097/TP.0b013e318271d7c1

K. Fennie, C. Bova, and A. Williams, Adjusting and Censoring Electronic Monitoring Device Data, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.Supplement 1, p.88, 2006.
DOI : 10.1097/01.qai.0000248336.97814.2f

C. Wendel, M. Mohler, K. Kroesen, N. Ampel, A. Gifford et al., Barriers to Use of Electronic Adherence Monitoring in an HIV Clinic, Annals of Pharmacotherapy, vol.278, issue.9, pp.357-644, 2000.
DOI : 10.1345/aph.10349

K. Berg and J. Arnsten, Practical and Conceptual Challenges in Measuring Antiretroviral Adherence, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.Supplement 1, p.79, 2006.
DOI : 10.1097/01.qai.0000248337.97814.66

D. Bangsberg, T. Barclay, C. Hinkin, and S. Castellon, Less Than 95% Adherence to Nonnucleoside Reverse???Transcriptase Inhibitor Therapy Can Lead to Viral Suppression, Clinical Infectious Diseases, vol.43, issue.7, pp.939-979, 2006.
DOI : 10.1086/507526

C. Pearson, J. Simoni, P. Hoff, A. Kurth, and D. Martin, Assessing Antiretroviral Adherence via Electronic Drug Monitoring and Self-Report: An Examination of Key Methodological Issues, AIDS and Behavior, vol.33, issue.2, p.161, 2007.
DOI : 10.1007/s10461-006-9133-3

J. Simoni, C. Pearson, D. Pantalone, G. Marks, and N. Crepaz, Efficacy of Interventions in Improving Highly Active Antiretroviral Therapy Adherence and HIV-1 RNA Viral Load, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.Supplement 1, p.23, 2006.
DOI : 10.1097/01.qai.0000248342.05438.52

C. Golin, H. Liu, and R. Hays, A prospective study of predictors of adherence to combination antiretroviral medication, Journal of General Internal Medicine, vol.15, issue.10, p.756, 2002.
DOI : 10.1046/j.1525-1497.2002.11214.x

G. Ogedegbe, W. Chaplin, and A. Schoenthaler, A practice-based trial of motivational interviewing and adherence in hypertensive African Americans The impact of illicit drug use and substance abuse treatment on adherence to HAART Navigating hazardous conditions: understanding HIV medication adherence in the context of depression, 1134. 95. Wendorf AR, Mosack KE, pp.1137-94, 2007.

M. Carrieri, M. Chesney, and B. Spire, Failure to maintain adherence to haart in a cohort of French HIV-positive injecting drug users, International Journal of Behavioral Medicine, vol.35, issue.2, p.1, 2003.
DOI : 10.1207/S15327558IJBM1001_01

J. Moatti, M. Carrieri, B. Spire, J. Gastaut, J. Cassuto et al., Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment, AIDS, vol.14, issue.2, p.151, 2000.
DOI : 10.1097/00002030-200001280-00010

J. Arnsten, P. Demas, and R. Grant, Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users Nonadherence among HIV-infected injecting drug users: the impact of social instability, J Gen Intern Med J Acquir Immune Defic Syndr, vol.17, issue.31, p.149, 2002.

R. Cook, S. Sereika, S. Hunt, W. Woodward, J. Erlen et al., Problem drinking and medication adherence among persons with HIV infection, Journal of General Internal Medicine, vol.14, issue.suppl 1, p.83, 2001.
DOI : 10.1111/j.1525-1497.2001.00122.x

T. Lovejoy and J. Suhr, The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review, Journal of Behavioral Medicine, vol.23, issue.5, p.389, 2009.
DOI : 10.1007/s10865-009-9212-9

J. Cutler, P. Sorlie, M. Wolz, T. Thom, L. Fields et al., Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988-1994 and 1999-2004, Hypertension, vol.52, issue.5, p.818, 1988.
DOI : 10.1161/HYPERTENSIONAHA.108.113357

M. Johnson, S. Catz, and R. Remien, Theory-Guided, Empirically Supported Avenues for Intervention on HIV Medication Nonadherence: Findings from the Healthy Living Project, AIDS Patient Care and STDs, vol.17, issue.12, p.645, 2003.
DOI : 10.1089/108729103771928708

L. Feinstein, R. Anderson, T. M. Sorhaindo, A. Hammond, and C. , Measuring the effects of education on health and civic engagement: proceedings of the copenhagen symposium, 2006.

J. Assal, Cost-Effectiveness of Diabetes Education, PharmacoEconomics, vol.8, issue.Supplement 1, p.68, 1995.
DOI : 10.2165/00019053-199500081-00015

D. Simoni, A. Hardeman, W. Mant, J. Farmer, A. Kinmonth et al., Trials to Improve Blood Pressure Through Adherence to Antihypertensives in Stroke/TIA: Systematic Review and Meta-Analysis, Journal of the American Heart Association, vol.2, issue.4, p.251
DOI : 10.1161/JAHA.113.000251

N. Qureshi, J. Hatcher, N. Chaturvedi, and T. Jafar, Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial, BMJ, vol.335, issue.7628, p.1030, 2007.
DOI : 10.1136/bmj.39360.617986.AE

T. Fahey, K. Schroeder, and S. Ebrahim, Interventions used to improve control of blood pressure in patients with hypertension, Cochrane Database Syst Rev, issue.2, p.5182, 2006.

N. Campbell, E. Murray, and J. Darbyshire, Designing and evaluating complex interventions to improve health care, BMJ, vol.334, issue.7591, p.455, 2007.
DOI : 10.1136/bmj.39108.379965.BE